karen-firestone-headshot-views-page

Views/Blog

APPLYING PRACTICAL INSIGHT TO
COMPLEX FINANCIAL CONCEPTS

Karen Firestone has spent over thirty years honing skills applied to
the investment world, while at the same time navigating a path through the work/familyscape. She considers many issues from an unusual angle, including stock market movement, factors facing professional women today, and how to think in simple terms about some complex financial structures. Karen shares her observations in posts that also appear in the Harvard Business Review and Huffington Post. As the CEO of Aureus Asset Management, a former fund manager at Fidelity Investments, and the mother of four grown children, Karen has a rare perspective into which she injects humor and some irreverence.

HBR: Think About Any Risk Like an Investor

Risk Dice

By Karen Firestone Kari recently wrote a piece for the Harvard Business Review about how the four tenets of risk taking can apply to any situation. You can purchase a copy of her book by following this link. Read her article in The Harvard Business Review

[VIEW FULL POST]

NYT – The Recovery’s Two Sides: Weak Growth Even as Hiring Surges

By NELSON D. SCHWARTZ The trajectory of the economic recovery remains frustratingly uneven nearly seven years after it began — but plenty is going right at the same time. Jobs up,  GDP weak, but there are signs that second half will benefit from the weaker dollar and higher energy prices. Read the full article in…

[VIEW FULL POST]

Squawk Box: Don’t trust GDP numbers

Nariman Behravesh, IHS chief economist, and Karen Firestone, Aureus Asset Management, provide their outlook the economy after the fed signals it’s not in a rush to raise interest rates. Watch the full video on CNBC.com

[VIEW FULL POST]

Kari on Dot Complicated’s #52women52weeks

Kari has been recognized by Dot Complicated with Randi Zuckerberg (which airs on SiriusXM Channel 111) in its #52women52weeks campaign, where the show recognizes a woman in business once a week for a full year. Check out the conversation on her LinkedIn page here

[VIEW FULL POST]

WSJ: U.S. Drug Spending Climb

By PETER LOFTUS April 14, 2016 12:01 a.m. ET The new Hepatitis C drugs are accounting for much of this increase.  Will it be worth it to have brought such headline risk to the industry? Read the full article in The Wall Street Journal

[VIEW FULL POST]